CJC-1295 2 mg x 5 Vials – Thaiger Pharma

Description

Thaiger Pharma CJC-1295 2 mg is a sophisticated research peptide developed for scientists investigating the body’s natural regulation of Growth Hormone Releasing Hormone (GHRH) and its influence on endocrine function. Designed to mimic the activity of endogenous GHRH, CJC-1295 has become an important research tool for exploring the molecular mechanisms that govern growth hormone signaling, hormone pulsatility, and long-term endocrine communication.

Unlike peptides that directly stimulate growth hormone secretagogue receptors, CJC-1295 is extensively researched for its ability to engage the GHRH receptor, allowing investigators to study the upstream regulation of growth hormone release. This unique mechanism makes it particularly valuable in laboratory settings focused on hormone physiology, peptide pharmacology, receptor biology, and metabolic research.

Each package contains 5 lyophilized vials, with 2 mg of CJC-1295 per vial, offering researchers a reliable, high-purity formulation for advanced scientific investigations. Manufactured by Thaiger Pharma, every batch is produced under strict pharmaceutical-quality standards to ensure exceptional purity, stability, and consistency.

Key Features

• Premium CJC-1295 research peptide
• 2 mg of CJC-1295 per vial
• 5 lyophilized vials per pack
• Synthetic analogue of Growth Hormone Releasing Hormone (GHRH)
• High-purity laboratory-grade formulation
• Extensively studied in endocrine physiology and peptide research
• Suitable for investigations involving GHRH receptor activation, hormone signaling, growth factor regulation, and metabolic biology
• Manufactured under stringent quality control standards
• Intended exclusively for laboratory and scientific research applications

How It Works

CJC-1295 functions by selectively interacting with Growth Hormone Releasing Hormone (GHRH) receptors located within the anterior pituitary, initiating intracellular signaling pathways associated with growth hormone regulation. Researchers commonly utilize this peptide to investigate the physiological processes responsible for endocrine communication, hormone pulsatility, and receptor-mediated signaling.

In laboratory studies, CJC-1295 is frequently examined for its influence on downstream IGF-1 production, peptide-receptor dynamics, and molecular pathways involved in cellular metabolism and growth factor biology. It is also widely used in comparative research evaluating the differences between short-acting GHRH analogues and long-acting modified peptides, providing valuable insights into peptide pharmacodynamics and endocrine regulation.

This formulation is intended exclusively for laboratory and scientific research and is not intended for human consumption.

Contents

Active Ingredient: CJC-1295 – 2 mg

Packaging: 5 Lyophilized Vials